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Trends exist even for the colour of mosquito nets. 
Colours are not only for the appearance but very 
important for being accepted. Nothing has changed 
regarding their purpose however, which is to pre-
vent people catching certain tropical diseases.
The images in this brochure show the Swiss 
Tropical and Public Health Institute (Swiss TPH) in 
Basel – a symbol of the many Swiss players active 
in education, research and services internationally. 
The brochure also shows images of the Geneva-
based World Health Organisation (WHO), which is 
the most important international platform for health 
issues. 
www.swisstph.ch
www.who.int
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Malaria cultures are grown in Petri dishes as part of research into new strategies to fight the disease. 
Malaria is a clear example of the worldwide dimension of health foreign policy. Half of humanity is 
threatened by malaria, but 80% of all deaths resulting from it occur in sub-Saharan Africa.
5As a result of globalisation, health issues 
are becoming increasingly important at 
the international level. A growing inter-
dependence between domestic and 
health foreign policy is apparent world-
wide. Health has also become a topic of  
Switzerland’s foreign policy and therefore 
a focused and multisectoral approach  
is required in order to ensure that funda-
mental Swiss values such as human 
rights, the rule of law and democracy are 
guaranteed, and also that the interests 
of a wide variety of Swiss actors can be 
taken into account. 
Underlying Swiss Health Foreign Policy 
are all the country’s international con-
cerns relating to health – with neighbour-
ing countries, in European policy, on 
the subject of global public goods, or in 
development policy. The policy is based 
on a concept of global health which – in 
contrast to the concept of international 
health that prevailed up to the turn of 
the century, focusing primarily on the 
health problems of the least developed 
countries – is concerned with strategies 
at the global level. Accordingly, prime 
responsibility rests with all countries, and 
not only – as in the conception of interna-
tional health – with donor and beneficiary 
countries.
The present Swiss Health Foreign Policy, 
a revised version of the 2006 Agreement 
on Health Foreign Policy Objectives, is 
the result of a consultation procedure 
involving the relevant federal authorities 
and interested parties from civil society, 
the private sector, research, Swiss health 
system actors and the Swiss Confer-
ence of the Cantonal Ministers of Public 
Health. It was approved by the Federal 
Council on 9 March 2012, has a medium-
term perspective and is to be reviewed 
as required, but after six years at the 
latest.
Approval by the Federal Council makes 
it possible to adopt a consistent posi-
tion in dealings with external partners. 
The broad outlines of the policy are in 
line with the previous direction of Swiss 
Health Foreign Policy. However, the 
experience of recent years provides an 
opportunity to make adjustments so as to 
ensure that, in the future, Switzerland can 
pursue an even more coherent and effec-
tive approach in the health field.
Health issues are becoming 
increasingly important
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Swiss scientists work with other scientists around the world, in this way raising the visibility of 
Switzerland’s commitment to international health foreign policy. The so-called 10/90 gap shows that 
only 10% of investment in research is channelled to work on diseases that affect 90% of the world’s 
population.
7Coherence within the Federal Adminis-
tration is a key success factor for Swiss 
Health Foreign Policy, even though this 
may not always be apparent from the 
outside. This explains the importance of 
various structural modifications within 
the departments responsible for global 
health. In the FOPH, the International Af-
fairs Division has been consolidated and 
global health has been confirmed as one 
of the Office’s eleven strategic activity 
areas. The FDFA Directorate of Political 
Affairs has established a health desk in 
the Sectoral Foreign Policies Division, 
included Swiss Health Foreign Policy 
in the introductory programme for new 
diplomats and is increasingly defining 
health-related objectives in agreements 
on objectives for foreign missions. The 
FOPH assigns a health attaché to Swit-
zerland’s Mission to the EU in Brussels. 
In the Swiss Agency for Development 
and Cooperation SDC, alongside the 
policy advisor function, two posts have 
been created for multilateral and inter-
national partnerships, and an internal 
knowledge-sharing health network has 
been developed. In addition, from 2013 
onwards a new global programme on 
health will strengthen the SDC’s mandate 
to advocate the Swiss perspective at the 
global level.
The Agreement on Health Foreign Policy 
Objectives concluded by the FDFA and 
FDHA – a pilot project representing 
the first interdepartmental agreement 
on objectives1 between the FDFA and 
another department with responsibility for 
a specific sector – was adopted in 2006 
for two years and subsequently renewed 
several times.
Switzerland was the first country to adopt 
an interministerial agreement on health 
foreign policy objectives. Since it was 
signed, the agreement has been regarded 
as a model at the international level. 
The Agreement on Health Foreign Policy 
Objectives represents an important 
working and control instrument for the 
Federal Administration. As illustrated by 
the various examples given in the follow-
ing boxes, the Agreement has substan-
tially improved cooperation between the 
various authorities in the health field, 
permitting results-oriented coordination 
and greater policy coherence. It has also 
encouraged reconciliation of differing 
positions and a readiness to compromise 
on the part of the authorities involved. 
This allows Switzerland to adopt a more 
uniform approach at the international 
level, thus strengthening the country’s 
role as a coherent and transparent nego-
tiating partner.
1 Based on the Federal Council Decree of 18 May 2005
Efforts to combat pandemic 
influenza
In September 2009, Switzerland decided to 
participate with other countries in the initiative 
launched by US President Barack Obama to 
donate pandemic influenza A (H1N1) vaccines 
to the least developed countries. Under this 
programme, Switzerland provided more than 
a tenth of the vaccine doses ordered by WHO, 
ultimately totalling 1.5 million vaccine doses 
supplied by WHO to Ethiopia. 
The logistical difficulties encountered by WHO 
in the global deployment of the pandemic in-
fluenza vaccine demonstrated the need for a 
system allowing for pre-planning. The Pan-
demic Influenza Preparedness (PIP) Framework 
adopted by the World Health Assembly in 2011, 
which aims to promote the sharing of influenza 
viruses and access to vaccines and other bene -
fits (thanks in particular to the contribution 
made by industry), will ensure more equit-
able access and greater international solidarity 
during future pandemics. This agreement was 
the result of a four-year negotiation process in 
which Switzerland played an active role.
Switzerland was the first country  
to adopt an interministerial agree-
ment on health foreign policy  
objectives
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The best protection against a mosquito-borne disease is prevention against mosquito bites. The 
Swiss TPH breeds mosquitoes in a special laboratory to test the effectiveness of different protective 
measures against carriers of the disease, such as the Anopheles mosquito.
9FOPH was responsible for industrialised 
countries and for WHO (technical matters 
and governance), while the SDC was 
responsible for developing countries 
and multilateral development matters. 
Today however, two thirds of the world’s 
population live in countries with emerg-
ing economies, which no longer expect 
traditional development cooperation, but 
exchanges among countries on an equal 
footing. Moreover, in multilateral negoti-
ations on questions such as access to 
medicines, the positions of large coun-
tries with emerging economies (BRICS)2  
in particular – given their economic and 
research policy interests – often differ 
from those of the least developed coun-
tries. Not infrequently, interests stemming 
from competition are mixed with those of 
health policy. This in turn raises special 
challenges for Switzerland in weighing up 
its own corresponding interests, necessi-
tating significantly closer cooperation be-
tween the federal authorities concerned.
Switzerland and numerous public and 
private actors in the country pursue 
intensive research on questions of global 
health. Especially in the context of de-
velopment cooperation, Switzerland has 
a long tradition of approaching health is-
sues from a global perspective. In the fu-
ture, this global focus is to be intensified 
in Swiss Health Foreign Policy activities 
by all the federal authorities concerned.
Swiss Health Foreign Policy has tradi-
tionally involved both concrete bilateral 
development cooperation in the least 
developed countries and multilateral ac-
tivities. Recent years have seen a steady 
increase in requests made to Switzerland 
for bilateral contacts with industrialised 
countries and countries with emerging 
economies. This applies to general health 
policy visits, specific contacts concerning 
health insurance, drug issues, food safety 
and communicable diseases, and also 
to health projects associated with Swiss 
cohesion payments to new EU member 
states. At the same time, international 
health issues are increasingly also being 
raised at bilateral visits of the Ministers 
of Foreign Affairs and Home Affairs as 
well as the directors of the federal offices 
concerned. Thus, apart from the thematic 
objectives of Swiss Health Foreign Policy, 
there will also be a need for coordination 
with Switzerland’s bilateral cooperation 
in the health field, in order to meet the 
growing demands in this area. 
As in most industrialised countries, 
Switzerland’s governmental structures in 
the post-war period were built based on 
a perceived dichotomy between indus-
trialised and developing countries – with 
the exception of the isolated Eastern 
bloc. With regard to international health 
issues, generally addressed in a purely 
technical manner, there was a clearly 
defined division of responsibilities: the 
2 Brazil, Russia, India, China, South Africa
The requests for bilateral contacts 
with industrialised countries and 
countries with emerging economies 
are increasing
10
With regard to the eight Millennium 
Development Goals (MDGs)3 – three of 
them directly concerning health4 – which 
were adopted in 2000 by all UN Member 
States, the question arises for the post-
2015 period of how the global develop-
ment goals can be improved and adapted 
to the respective environment so as to 
maintain or increase their positive effects. 
Here, greater weight should be accorded 
to global issues, human rights and sus-
tainability. In addition, there is a need for 
a conception of development involving 
a broader definition of poverty than that 
which is implicitly assumed at present 
3  With the adoption of the Millennium Declaration and the Millennium Development Goals in the year 2000, the UN members states were endeavouring to reduce extreme poverty  
in the world by half up to 2015.
4 MDG 4 (reducing child mortality), MDG 5 (improving maternal health) and MDG 6 (combating HIV/Aids, malaria and other diseases)
5 Swiss Federal Council, Millennium Development Goals – Progress Report of Switzerland 2010, June 2010, p. 40, see: www.deza.admin.ch/ressources/resource_en_193398.pdf
Local authority partnerships  
with China
Cooperation with China in the health field is 
being pursued on the basis of a Memorandum 
of Understanding concluded in 2005. For three 
years, Peking University and the Global Health 
Programme of the Graduate Institute of Interna-
tional and Development Studies in Geneva have 
been jointly organising courses on global health 
diplomacy, supported by the Chinese Ministry 
of Health and the FOPH. In addition, four part-
nerships are being developed between Swiss 
cantons and Chinese cities:
Canton Basel-Stadt & Municipality of Shanghai
Canton Geneva & Municipality of Shenzhen 
Canton Vaud & Municipality of Zhenjiang
Canton Zurich & Municipality of Kunming
On an official working visit to China (21–27 April 
2011), Federal Councillor Didier Burkhalter met 
with the Chinese Health Minister Chen Zhu and 
signed a joint declaration on bilateral coopera-
tion in the field of health; among other things, 
this establishes the institutional framework for 
the four partnerships mentioned above.
by the MDGs. Being developed means 
living in a society where as many people 
as possible have socially, environmentally 
and economically acceptable options for 
living in dignity.5 Account should be taken 
not only of access to education and 
health care, but also of vulnerability and 
insecurity, exclusion and powerlessness 
(ability to influence the underlying condi-
tions of poverty through political partici-
pation). This is based on recognition of 
the universal right, enshrined in the WHO 
Constitution, to enjoyment of the high-
est attainable standard of physical and 
mental health.
Breakdown of SDC health expenditure by   
Millennium Development Goals 2006–2009
Communicable diseases 41% Maternal mortality 32% Child mortality 27%
“Developed” means  
living a life in dignity
Challenges
11
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Access to essential medicines for all is one of the goals of Swiss Health Foreign Policy.
13
fore involve the state, civil society and 
the private sector alike. The principle of 
good governance is also a yardstick for 
Swiss Health Foreign Policy – both in its 
development and in its implementation.
Justice and poverty focus
Without health, no development is pos-
sible and, conversely, restricted oppor-
tunities for development have an impact 
on health. Switzerland supports the 
objective of global health, pursuing an 
approach based on human rights. The 
aim is thereby to achieve, firstly, equal 
access to health care for all worldwide 
(irrespective of origin, race, gender, age, 
sexual orientation, language, social pos-
ition, way of life, religious, ideological 
or political convictions, or of physical, 
mental or psychological disability). Also 
to be achieved, secondly, are greater 
social justice – by considering the needs 
of poor and vulnerable population groups 
within states – and an improved balance 
between high-, middle- and low-income 
countries. 
Global responsibility
Swiss Health Foreign Policy has the 
potential to enhance Switzerland’s cred-
ibility as a global actor in the health field 
and to highlight the commitment of Swiss 
development cooperation to poverty 
reduction and sustainable development 
as part of Switzerland’s national inter-
ests and shared global responsibility. 
Swiss Health Foreign Policy is guided by 
overarching principles and values, ap-
plicable to all the objectives.6
Good governance
Good governance is the exercise of 
political, economic and administrative 
authority to manage a society’s affairs at 
all levels. It comprises the mechanisms, 
processes and institutions through which 
citizens and groups articulate their inter-
ests, exercise their rights, meet their obli-
gations and mediate their differences.7 
In Swiss Health Foreign Policy, too, 
Switzerland has a substantial interest in a 
smoothly functioning multilateral system 
based on the rule of law and human 
rights, where corruption and inequalities 
are combated and democracy is pro-
moted. These are the necessary condi-
tions for political stability and thus for 
effective and sustainable development. 
Accordingly, governance is to be under-
stood as a relationship between citizens 
and the state, as the negotiation of a 
balance of power on an equal footing. 
Good governance does not only mean 
that the government and administration 
exercise their public duties responsibly, 
professionally and in accordance with the 
interests of the population. It also encom-
passes fruitful cooperation between state 
and private sector actors, and places 
certain responsibilities on citizens. Efforts 
to promote good governance must there-
6 For the goals see pp. 27–30
7 Adapted from “Governance for sustainable human development. A UNDP policy document, United Nations Development Programme 1997”
Efforts to control the main com-
municable diseases – the case  
of malaria
Each year, malaria affects over 200 million 
people, killing over 700,000 of them. Since the 
1990s, SDC has supported innovative projects 
designed to control this dangerous tropical 
disease in Tanzania, as well as local malaria 
research which has earned global recognition. 
One particularly successful approach has been 
the systematic distribution of insecticide-treat-
ed mosquito nets: use of these nets was shown 
to reduce the number of cases of malaria and 
child mortality. Following these encouraging 
results, the method attracted broader interest 
outside Tanzania and now forms part of na-
tional malaria control programmes supported 
by numerous organisations. The results are im-
pressive – the prevalence of malaria has been 
reduced in children aged under 5, contributing 
significantly to a reduction in child mortality. 
Over the past 5 years, the SDC has invested 
CHF 11 million annually in malaria control ef-
forts. It was investments of this kind that made 
it possible, for example, for 88 million bed nets 
to be distributed in sub-Saharan Africa in 2008. 
By 2008, thanks to this campaign, a third of 
all Tanzanian households had at least one in-
secticide-treated bed net, compared with only 
20% of households in 2006. In global efforts 
to combat malaria, Swiss research institutions, 
NGOs and companies play a key role. The Swiss 
Malaria Group (SMG) established by the SDC 
currently has 11 members. The aim of the SMG 
is to strengthen Switzerland’s commitment in 
this area, which has already proved success-
ful. One life-saving innovation, the antimalarial 
drug now most widely used in children, was 
jointly developed by the Medicines for Malaria 
Venture and Novartis – a public-private part-
nership financially supported by the SDC.
Swiss Health Foreign Policy 
is based on the rule of law 
and human rights
14
Safeguarding of interests  
and coherence
In both domestic and foreign policy, 
Switzerland has a variety of objectives to 
pursue. For example, Switzerland wishes 
to reconcile its commitment to a liberal 
economic order with the interests of soli-
darity and global health. In the measures 
designed to achieve these objectives, 
therefore, the greatest possible coher-
ence should be sought, synergies should 
be developed, and inevitable conflicts 
of interests should be openly addressed 
and resolved via the existing political 
decision-making mechanisms.
If Switzerland is to successfully safeguard 
its interests in today’s globalised world, 
it is important that it should continue to 
pursue diversified approaches – be it 
geographically, institutionally or thematic-
ally. The foreign policy instruments de-
ployed need to be sufficiently adaptable 
to accommodate a constantly changing 
international environment.
The growing importance of the health 
field brings new challenges and opport un-
ities for Swiss foreign policy. International 
cooperation on health has intensified, 
and new international legal instruments 
are being established. There are grow-
ing calls for international standards and 
greater international cooperation in view 
of steadily rising costs, the increasing 
mobility of patients, health personnel and 
services, and growing technical com-
plexity. The Aids pandemic or the H1N1 
influenza pandemic have shown that, in 
Principles and values
This involves not only effective disease 
control measures, but an integrated 
approach, taking account of key health 
determinants such as income, education, 
nutrition, environment and water, as well 
as social factors such as discrimination 
against women. Today, health is one of 
the core responsibilities of every foreign 
minister, and every health minister has 
a dual responsibility – for public health 
at home and for helping to shape global 
health policy.
These global responsibilities are en-
shrined, to a great extent, in the Swiss 
Federal Constitution8 and in the WHO 
Constitution.9 The objective of WHO is to 
promote the attainment by all peoples of 
the highest possible level of health. The 
aims specified in the Federal Constitution 
have a substantial influence on health. In 
this connection, special mention should 
be made of the common welfare, sustain-
able development, the greatest possible 
equality of opportunity, long-term preser-
vation of natural resources, and a just 
and peaceful international order.
With regard to foreign policy, Art. 54 
Para. 2 of the Federal Constitution states 
that the Confederation is to ensure that 
the independence of Switzerland and its 
welfare is safeguarded; in particular, it is 
to promote the alleviation of need and of 
poverty in the world, respect for human 
rights and democracy, the peaceful co-
existence of peoples and the conserva-
tion of natural resources.
8 In particular, the Preamble, Art. 2 “Aims” and Art. 54 “Foreign relations”
9 SR 0.810.1 (English version: http://www.who.int/governance/eb/who_constitution_en.pdf), in particular the Preamble and Art. 1 
Health, a key to poverty reduction
Even in the absence of crises, weak or defi-
cient health systems are the rule in many of the 
least developed countries and of the countries 
with economies in transition. In recent years, 
the SDC has increased its financial contribu-
tions to health programmes, also supporting 
international efforts and global initiatives. It 
promotes health care which benefits especially 
poorer population groups and reduces major 
inequalities in access to health services. Even 
though new challenges are constantly arising, 
progress has been achieved in those countries 
where Switzerland is active in the health field 
and, together with other donor countries, helps 
to build state capacity through budgetary sup-
port in the health sector. This progress has 
been facilitated by the expertise and numerous 
partnerships of the SDC, coordination between 
donor countries, efficient use of resources and 
many years of experience. In SDC priority coun-
tries Tanzania and Mozambique, child mortality 
has declined by more than a third over the last 
10 years; in Moldova, it has decreased by 40% 
since 2000. In sub-Saharan countries, a third 
fewer children were infected with HIV in 2009 
than in 2004, and in 11 African countries new 
cases of malaria have been reduced by more 
than 50%.
Health is one of the core respon-
sibilities of every foreign minister
15
a globalised world, globally coordinated 
action based on solidarity is essential  
to protect the public. At the same time, 
non-communicable diseases10, for ex-
ample – with multiple causes such as 
diet, lifestyle or environmental factors – 
call for a new kind of (preventive)  
approach, encompassing a wide variety 
of actors and sectors.
A coherent Swiss Health Foreign Policy 
seeks synergies between different policy 
sectors. The long-term aim is that, in 
each of the sectors concerned, “better” 
policies can be pursued, strengthening 
the credibility, transparency and effective-
ness of Swiss policy as a whole.
“Swissness” – building on existing 
strengths
In its Health Foreign Policy, Switzerland 
also builds primarily on its own strengths. 
Switzerland has one of the best health 
systems11, outstanding global health 
research centres, a strong, innovative 
pharmaceutical and medtech industry, 
and a long humanitarian tradition. Health 
is one of the top priorities of Switzer-
land’s development cooperation. Its 
health research and teaching is of a high 
class internationally.
Switzerland is thus an attractive partner 
with a great deal to offer both in develop-
ment cooperation and in exchanges with 
health ministries. As the host country 
for the most important international 
organisations in the health sector, and 
with its political culture of consensus and 
neutrality, Switzerland can also benefit 
from its comparative advantages in 
multilateral activities, both representing 
its own interests and assuming significant 
responsibility for global health.
10 Cancer, diabetes, cardiovascular diseases, chronic respiratory diseases
11 According to OECD/WHO 2011: OECD Reviews of Health Systems: Switzerland 2011
Health centres: 
village communities participate
In close cooperation with the local population, 
Switzerland has been involved in the develop-
ment of 7 hospitals and 76 health centres in 
Rwanda and Burundi. Motivated by the active 
participation of village communities, health ad-
visors, medical personnel, traditional midwives 
or youth groups have collaborated in projects. 
Over a million people in the African Great Lakes 
region are benefiting from improved medical 
services and health education, which generally 
leads to improvements in health.
Swiss Health Foreign Policy is 
built on Switzerland’s strengths
16
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Federal Councillor Alain Berset and WHO Director-General Dr Margaret Chan at the 65th World 
Health Assembly in Geneva. Reform of the WHO is an important project both for Switzerland  
and the Director-General.
17
Maternal and infant health
Depending on where an expectant mother lives, 
pregnancy can be more or less risky. Maternal 
and child mortality is largely determined by 
whether medical care is provided in good time – 
or is even available. Non-existent or poor-quality 
health care is still one of the main reasons for 
deaths occurring during pregnancy, in childbirth 
and during the postnatal period. To reduce infant 
mortality and improve maternal health, Switzer-
land is therefore relying on optimised basic care 
for mothers and infants. In the sub-Saharan 
countries and in the transitional countries of 
Eastern Europe, the SDC has been involved in 
efforts to improve infrastructure and equipment 
in health centres and to provide training for phy-
sicians, nursing staff and midwives. Between 
1990 and 2008, thanks to efforts by the SDC 
and other partners to develop basic medical 
care, the proportion of professionally attended 
births in sub-Saharan countries rose from 53% 
to 63%, while maternal mortality declined. A 
decline in maternal and infant mortality has 
also been recorded in Eastern European partner 
countries.
The FDFA and the FDHA, or the Sectoral 
Foreign Policies Division of the FDFA 
(SFPD), SDC and the FOPH respectively, 
are the federal authorities most closely 
involved in Swiss Health Foreign Policy. 
At the same time, the concerns of other 
federal authorities are to be taken into 
account in the policy. Specifically, the 
authorities in question are the United 
Nations and International Organisations 
Division (UNIOD) and the Human Security 
Division (HSD) of the FDFA, the FDFA/
FDEA Integration Office, the Federal Sta-
tistical Office (FSO), the State Secretariat 
for Education and Research (SER), the 
Federal Office for Migration (FOM), the 
Swiss Federal Institute of Intellectual 
Property (IPI), the Armed Forces Logistics 
Organisation (AFLO), the State Secre-
tariat for Economic Affairs (SECO), the 
Federal Office for Professional Education 
and Technology (OPET) and the Federal 
Office for the Environment (FOEN). Other 
authorities involved in relation to specific 
topics include the Federal Social Insur-
ance Office (FSIO), the Swiss Agency for 
Therapeutic Products (Swissmedic), the 
Swiss Alcohol Board (SAB), the Federal 
Veterinary Office (FVO) and the Federal 
Office for Agriculture (FOAG). 
The present Swiss Health Foreign Policy 
recognises and utilises the existing 
competences of the various federal 
authorities. The complexity of the chal-
lenges arising with regard to coher-
ence is demonstrated by the numerous 
policy areas which are relevant to Swiss 
Health Foreign Policy. Through closer 
cooperation, the policy as a whole is to 
become more targeted and synergies 
are to be exploited wherever possible. 
Foreign policy coherence and more ef-
fective safeguarding of interests are the 
overarching objectives which are to be 
achieved through enhanced coordination 
among the federal authorities.12
Swiss Health Foreign Policy is influenced 
not only by the federal authorities in-
volved but also, to a considerable extent, 
by other Swiss actors and partners:
•  Since health policy is largely also a can-
tonal responsibility, the Swiss Confer-
ence of the Cantonal Ministers of Public 
Health (GDK) is a key partner for Swiss 
Health Foreign Policy. It will therefore 
continue to be involved in policy activi-
ties and be invited to meetings of the 
Interdepartmental Conference (IK GAP) 
and the Interdepartmental Working 
Group (IdAG GAP).13
•  In Swiss Health Foreign Policy, as 
in all other policy areas, exchanges 
take place with the Swiss Parliament 
(Foreign Affairs Committee/FAC, Com-
mittee for Social Security and Health/
CSSH).
•  Among the other key actors are NGOs, 
including organisations active in Swit-
zerland, such as the Swiss Society for 
Public Health and the various health 
leagues, and others active in develop-
12  As for all international relations, the principles concerning mandatory consultation, dealings with other countries and treaties concluded with foreign parties as set out in the         
Directives of 29 March 2000 on conducting international relations by the federal administration are also applicable to foreign health policy.
13 For a list of federal authorities participating in the IdAG GAP or involved in relation to specific topics, see Annex I
Coherence and more effective 
safeguarding of interests are 
the overarching objectives
18
ment cooperation, e.g. Medicus Mundi 
Switzerland (MMS), Médecins Sans 
Frontières (MSF), Berne Declaration.
• Professional associations, e.g. those for 
physicians (FMH) or nurses (SBK/ASI).
•  Health research and teaching (e.g. the 
Swiss Tropical and Public Health Insti-
tute, the Geneva University Hospitals, 
the Graduate Institute of International 
and Development Studies).
•  Health service providers (such as hos-
pitals, insurers).
•  Private sector (pharmaceutical, med-
tech, food industry).
Completing the picture are actors from 
other sectors with an interest in Swiss 
Health Foreign Policy and the numerous 
Swiss-based international organisations 
and public-private partnerships, such as 
the Medicines for Malaria Venture (MMV) 
or the Drugs for Neglected Diseases 
initiative (DNDi).
These actors – sometimes in coopera-
tion with federal authorities, sometimes 
independently – contribute to Swiss 
Health Foreign Policy. Their experience 
and knowledge feed into health research, 
contribute to national policies in partner 
countries and help to raise public aware-
ness in Switzerland and abroad. 
The World Health Organization (WHO), 
other UN agencies (e.g. UNAIDS, 
UNICEF or UNFPA), the World Bank 
and the OECD are the most important 
international organisations active in the 
health field. 
Through regulation and via agencies such 
as the European Food Safety Authority 
(EFSA) and the European Centre for Dis-
ease Prevention and Control (ECDC), the 
EU exerts an influence in numerous areas 
on the health systems and health policy 
measures of EU Member States and also 
of other countries. In addition, recent 
years have seen the emergence – along-
side existing funding institutions (World 
Bank, regional development banks, etc.) 
– of influential new international funding 
mechanisms and partnerships: these 
include global health initiatives – e.g. the 
Global Fund to Fight Aids, Tuberculosis 
and Malaria (GFATM) and the Global 
Alliance for Vaccines and Immunisa-
tion (GAVI) – and also public-private 
partnerships (PPPs) or product develop-
ment partnerships (PDPs), such as the 
Medicines for Malaria Venture (MMV), the 
Drugs for Neglected Diseases initiative 
(DNDi) or the Foundation for Innovative 
New Diagnostics (FIND).
The global aid architecture is undergoing 
a process of profound change, turning 
into a highly fragmented arena. In inter-
national health cooperation, likewise, the 
world has become multipolar, with a large 
number of new actors. New cooperation 
mechanisms are developing whereby 
actors such as countries with emerging 
economies, foundations and the pri-
vate sector can be involved in working 
towards shared objectives agreed at the 
international level.
Actors
Activities in the area of access  
to essential medicines
Switzerland was closely involved in the process 
which led, in 2008, to the adoption by the World 
Health Assembly of the Global Strategy and Plan 
of Action on Public Health, Innovation and Intel-
lectual Property. This is designed to promote re-
search and development and to improve access 
to medicines for diseases affecting the least de-
veloped countries in particular. The WHO Com-
mission on Intellectual Property Rights, Innova-
tion and Public Health (CIPIH), which produced 
the report and recommendations on which the 
strategy is based, was chaired by former Feder-
al Councillor Ruth Dreifuss. Consequently, Swit-
zerland played a key role throughout the nego-
tiations for this strategy and plan of action. At 
the national level, a document was developed 
for the implementation of the plan of action 
in Switzerland, integrating the activities of the 
federal authorities concerned (SDC, SER, SECO, 
IPI, FOPH) but also of external actors (NGOs, 
public-private partnerships, pharmaceutical 
industry, scientific community); this document 
was published on the occasion of the 64th World 
Health Assembly in 2011.
The global health architecture is 
undergoing a process of profound 
change
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In global health, this already complex 
architecture interacts with global public 
goods issues, such as protection against 
pandemics and representation of the 
economic interests of all countries in one 
of the largest and most rapidly growing 
sectors. In addition, new models of coop-
eration are being pursued, e.g. between 
industrialised countries and countries 
with emerging economies, where the 
focus is not primarily on funding, but on 
sharing of experience. All countries face 
certain common challenges, such as 
strengthening health systems, demo-
graphic changes, or influencing social 
determinants of health.
14  WHO, UNICEF, UNFPA, UNAIDS, GFATM, GAVI, the Bill and Melinda Gates Foundation and the World Bank
There is a need to identify new forms of 
cooperation or ways of exploiting syner-
gies – initial efforts in this direction can 
already be seen in informal coordination 
mechanisms such as the Health 8 group 
(H8).14 One direct result of recent trends 
is the reform process initiated within 
WHO in 2010. Given the multiplicity of 
new health actors, WHO now faces the 
challenge of clearly articulating its role in 
a globalised world, redefining its leader-
ship function within global health govern-
ance, and more closely involving a wide 
variety of global health policy stakehold-
ers in WHO activities.
Migration and health personnel
In 2008, an interdepartmental working group 
was established, under the aegis of the FOPH, to 
prepare for negotiations on and implementation 
of the WHO Global Code of Practice on the Inter-
national Recruitment of Health Personnel, which 
was adopted in May 2010. This group, whose 
main objective is to investigate the role played 
by Switzerland in the global shortage of health 
personnel, commissioned studies from three 
institutions concerning 1) statistical documen-
tation (Obsan), 2) recruitment practices (GDK) 
and 3) international cooperation practices 
(Swiss TPH). The three reports were presented 
at the 12th Conference on National Health Policy, 
held in Bern in November 2010. It was conclud-
ed in particular that greater emphasis should 
be placed on training and retention of Swiss 
health personnel; in addition, a broad aware-
ness is currently lacking in Switzerland of the 
principle, laid down in the Code, whereby both 
source and destination countries should derive 
benefits from international migration. The group 
is continuing its work with a view to identify-
ing ways of remedying this situation; the first 
report on activities concerning implementation 
of the Code in Switzerland is due to appear in 
May 2012.
WHO must clarify its role 
in a globalised world
20
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Twenty-one international organisations are based in Geneva. They have all concluded host country 
agreements with the Confederation. WHO, which was founded in 1948, is among them. Switzerland 
is a member of the WHO Executive Board for the period 2011–2014, and wants to contribute to 
strengthening the organisation.
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Experience with Swiss Health Foreign 
Policy in recent years has shown that 
it is desirable to improve integration of 
the wide variety of activities in the health 
field, taking a more systematic approach 
to the development of synergies. It has 
become clear that current challenges 
need to be addressed holistically (e.g. 
health personnel migration), and that ex-
isting health risks often have multisector-
al causes and consequences (e.g. non-
communicable diseases). This applies at 
the local, national and global level. Better 
use is to be made of integration and the 
development of synergies among the 
various objectives and actors. 
With the revision of Swiss Health Foreign 
Policy, three areas of interest are defined:
• Governance
•  Interactions with other policy areas
• Health issues
These goal areas cover the health inter-
ests of the Swiss population, Switzer-
land’s global responsibility and general 
interests (cf. the matrix in Annex III). 
Area of interest 1: Governance
Since its establishment, WHO has been 
the key agency and dominant internation-
al forum for health issues, especially in 
the normative area. However, the last ten 
years have seen the emergence of a large 
number of new state, private and mixed 
institutions, which have rapidly devel-
oped into significant actors in the health 
field, sometimes with massive financial 
resources. As a result, the global health 
architecture has become more complex, 
and governance at the global level more 
difficult. Switzerland has a substantial 
interest in improving the effectiveness of 
global and international health coopera-
tion. It is therefore seeking to promote 
more coherent interaction among the 
relevant actors from the sectors of health, 
development cooperation, humanitarian 
aid, human rights and other health- 
related policy areas, be it at the bilateral 
level – especially in relations with the 
EU, but also in bilateral development 
cooperation – in multilateral bodies or in 
the context of the WHO reform process. 
There should be further strengthening of 
health policy synergies in international 
Geneva, which is home to 21 interna-
tional organisations having a host country 
agreement with the Swiss government 
(including WHO, UNAIDS, GFATM, 
WTO, ILO), the permanent missions of 
168 countries, various partnerships and 
convention secretariats, 250 international 
NGOs, and a wide variety of university 
and research institutes.  
Synergies in health policy should be 
further strengthened in international 
Geneva
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This may involve providing support for 
the Member Countries of these organisa-
tions in their capital cities and in Geneva, 
so that these countries can participate 
effectively in global health debates. In ad-
dition, scientific foundations and teach-
ing in the field of health diplomacy and 
governance are to be made available in 
international Geneva.
Swiss Health Foreign Policy is also to 
focus on the promotion of effective, high-
quality, affordable and equitable health 
systems in all countries – but especially 
in the least developed and in countries 
with economies in transition –, so as to 
reduce the existing inequalities in this 
area. In healthcare provision, the inter-
national dimension is rapidly increasing 
as a result of technical developments 
and the migration of patients and health 
personnel. Switzerland has an interest in 
learning from international experience in 
this area so that the Swiss health system 
can be further developed while remaining 
affordable. In this connection, increased 
exchanges on best practices should be 
pursued with other OECD countries, 
selected countries with emerging econo-
mies and the Commonwealth Fund15, 
with which Switzerland has maintained  
a partnership since 2008. 
Areas of interest
15  The Commonwealth Fund is a US-based private foundation. Since 1998, it has conducted annual comparative international health policy surveys.
Area of interest 2: Interactions  
with other policy areas 
Worldwide, consideration of health deter-
minants is playing an increasingly central 
role. After all, human health is influenced 
to a considerable extent by economic, 
social and environmental factors such 
as income, education, access to water, 
nutrition, natural resources, chemicals, 
waste management and gender equality.
Switzerland’s prosperity is one of the 
main determinants of health, and the 
health of the population, together with 
the quality of the health system, is a sig-
nificant locational factor. The therapeutic 
products industry (pharmaceuticals and 
medtech), accounting for around 36% of 
exports of goods, is Switzerland’s most 
important export sector. It is constantly 
confronted with the conflicting de-
mands of innovation, universal access to 
good-quality medicines and profitability. 
Equally, it has to address the needs of 
the least developed countries in the pro-
duction and adequate disposal, pricing 
and marketing of vital medicines, and in 
the development of their own research 
capacity. The health sector is one of 
the country’s leading employers. This 
indicates the economic significance of 
Swiss Health Foreign Policy, especially if 
one takes into account that these data on 
The therapeutic products industry 
is Switzerland’s most important 
export sector
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exports and jobs do not include related 
areas, such as the food and beverage 
industry. 
Switzerland exercises its global responsi-
bility for combating poverty and promot-
ing sustainable development, contributes 
– as a centre of scientific and academic 
research and training in the health field –  
to important advances in basic and  
applied research, and has an interest in a 
sound, non-discriminatory framework at 
the international level. With the devel-
opment of new, more effective drugs 
by companies based in or carrying out 
research and production in Switzerland, 
added value is created, which should be 
encouraged both from an economic and 
from a health policy perspective.
Switzerland’s specific contribution should 
consist in striking a responsible bal-
ance between the legitimate profitability 
interests of industry and universal access 
to good-quality therapeutic products (see 
the case of malaria, page 13). 
Area of interest 3: Health issues 
Through efforts to combat diseases and 
strategies for coping with existing dis-
ease burdens, public health and produc-
tivity are to be maintained. Targeted ef-
forts are still required to combat the three 
main poverty-related diseases (HIV/Aids, 
tuberculosis and malaria). Also required 
are continuing efforts to maintain a high 
level of protection in the areas of food 
safety, chemicals, radiological protection, 
environmental protection and safety of 
therapeutic products. At the same time, 
successful public health projects – at 
both the national and the global level – 
are now less frequently based on strictly 
vertical approaches designed to address 
a specific health challenge.
Health promotion is an important element 
in the public health sector. Especially 
in relation to non-communicable dis-
eases (cancer, diabetes, cardiovascular 
diseases, chronic respiratory diseases), 
contributions should be made to global 
strategies and programmes of a preven-
tive nature, using the existing channels 
and the resources already available to 
development and health organisations.
With regard to Switzerland’s development 
cooperation, the focus is on improving 
the health of poor and vulnerable popula-
tion groups. Particular efforts are required 
to improve maternal and child health, as 
well as improving sexual and reproduc-
tive health. Non-discriminatory access 
to basic preventive and curative health 
services should be assured for as many 
people as possible – irrespective of their 
socioeconomic status. This requires the 
Particular efforts are required to 
improve maternal and child health
24
existence of a global market for good-
quality, but inexpensive, medicines, vac-
cines, diagnostics and medical devices.
Education and training of health person-
nel – and the creation of incentives to 
motivate staff to remain in these occupa-
tions – need to be strengthened both in 
Switzerland and in the least developed 
countries. A partnership-based approach 
is essential if sufficient numbers of health 
personnel are to be recruited over the 
long term while avoiding the migration 
Areas of interest
Strengthening cooperation 
between the OECD and WHO
For some years, Switzerland has been seeking 
to strengthen cooperation between the OECD 
and WHO. In particular, it funded the second-
ment of a WHO expert to the OECD for a period 
of two years. It also provided financial support 
for a WHO-OECD hosted dialogue on health 
personnel migration, held in Geneva in October 
2008.
On two occasions, Switzerland has also re-
quested these two organisations to conduct a 
joint analysis of the Swiss health system. These 
reviews, published in October 2006 and Octo-
ber 2011, provide an overview of this country’s 
system, in both economic and public health 
terms. They also serve as a “portrait” for coun-
tries interested in Switzerland’s health system.
or “luring” of personnel from countries 
where they are urgently needed.
In the context of complex emergencies, 
humanitarian aid is complementary to 
development cooperation. Switzerland 
provides humanitarian assistance to 
the people most severely affected by a 
crisis, conflict or natural disaster. In such 
cases, humanitarian missions will include 
measures to promote health over the 
long term.
A partnership-based approach  
is essential if sufficient numbers 
of health personnel are to be  
recruited over the long term
25
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A group of researchers is examining the spread of tuberculosis throughout the world. Creating better 
conditions for research in the field of global health is another objective of Swiss Health Foreign Policy.
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1. Swiss-EU relations
Establish a legal framework for collabora-
tion with the EU on health and consumer 
protection matters.
• An agreement in the areas agriculture, food 
and product safety, and public health is con-
cluded with the EU.
• Switzerland participates in the key health-
related EU institutions and early warning 
systems (ECDC, EWRS, EFSA, RASFF) and 
in the Health Programme.
• Switzerland supports the new EU Mem-
ber States in the implementation of health 
standards.
• Health policy exchanges with individual EU 
countries are actively pursued.
2. Role of WHO
Strengthen WHO as the leading, coordinat-
ing global health authority.
• WHO reform is successfully completed.
• The normative role of WHO is strength-
ened.
• The positive impact of WHO on interna-
tional Geneva is recognised and fostered.
• As an Executive Board member (2011–
2014), Switzerland makes an active contri-
bution to strengthening WHO.
3. Global health 
       architecture
Improve the effectiveness, efficiency and 
coherence of the global health architecture.
• WHO fulfils its role as the leading, coor-
dinating global health authority and is ac-
cepted as such by other actors.
• There is no further increase in the fragmen-
tation of the global health architecture.
• International actors focus more effectively 
on their comparative advantages (normative 
role, financing, operational implementation, 
etc.).
• While the role of states is preserved, non-
governmental actors are better integrated 
into global health debates and activities.
4. Strengthening of health  
       systems
Place at the centre of Swiss Health Foreign 
Policy the promotion of effective, high- 
quality, affordable and equitable health 
systems.
• Multilateral (including OECD, WHO) and bi-
lateral comparisons yield important findings 
for the further development of Switzerland’s 
health system.
• Swiss development cooperation prioritises 
measures which strengthen health systems 
in the least developed countries and in 
countries with economies in transition.
• The relevant international organisations seek 
to strengthen the health systems of all coun-
tries, regardless of their development status.
• Optimum support is provided for interna-
tional networking of the main actors of Swit-
zerland’s health system, so as to facilitate 
learning from international good practices.
5. Health diplomacy
Integrate health as a key element of foreign 
policy.
• Switzerland takes an active part in debates  
on global health and foreign policy, strength-
ening cross-sectoral coherence and con-
crete results.
• Health is part of the training of Swiss diplo-
mats.
• The Geneva Programme for Global Health 
Diplomacy and Governance is developed 
and firmly established, thus helping to 
strengthen international Geneva.
6. International Geneva
Consolidate and strengthen Geneva’s posi-
tion as the “health capital of the world”. 
• Geneva is perceived internationally as the 
world’s “health capital”.
• Switzerland continues to support the inter-
national organisations – including WHO – 
with facilities and infrastructure and ensures 
that Geneva remains an attractive location 
for international organisations.
• In relation to the renovation of WHO build-
ings, Switzerland supports financing in 
accordance with the Capital Master Plan 
and relies on contributions from all member 
countries. 
• The “Campus Santé” project is implement-
ed.
The following twenty objectives – and the associated results/measures – are to be understood as objectives 
to the attainment of which Switzerland makes a significant contribution within the scope of its capacities and 
resources, since some of them cannot be attained by Switzerland alone. Responsibility for operational imple-
mentation rests largely with the federal authorities (acting alone or jointly) whose mandates and strategies  
are to be defined in accordance with Swiss Health Foreign Policy.
GOvERnAnCE
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7. Research
Establish conditions for the strengthening 
of global health research.
• Switzerland’s strengths as a research loca-
tion are used for global health purposes.
• Existing and new Swiss global health 
research actors work together, exploiting 
synergies for international research collabo-
ration.
• The SDC-SNSF programme for research on 
global questions with a focus on the public 
health sector stimulates Swiss global health 
research.
• The latter is more strongly oriented towards 
the most pressing health problems of the 
least developed countries and countries 
with emerging economies.
• Policy dialogue and the programmes of the 
federal authorities concerned are influenced 
by relevant findings from the SDC-SNSF re-
search programme “Provision systems and 
financing mechanisms in the public health 
sector”.
• Switzerland’s research results contribute to 
innovation and improvements in quality. 
• Better use is made of existing funding 
instruments, according to the respective 
framework conditions, for global health 
research.
8. Economic interests
Position the strengths of Switzerland’s 
health sector economy internationally.
• There is an increased awareness of local 
and global responsibilities in representing 
the economic interests of Swiss actors  
in the health sector.
• The visibility of the quality advantages of 
Switzerland’s health system is enhanced  
in the international context.
• Free trade is promoted.
9. Protection of intellectual  
       property
Provide appropriate protection for intel-
lectual property (IP) as an incentive for 
research.
• The IP system is further developed so as to 
ensure that incentives for research are not 
weakened, access to essential medicines is 
promoted, and consideration is given to the 
particular requirements of public health in 
the least developed countries.
• The application of TRIPS flexibilities in 
emergency situations is recognised.16
• New models and partnerships for the 
development of essential medicines and 
diagnostics are assessed and, if appropri-
ate, supported.
• The IP system is recognised internation-
ally for its contributions to the research and 
development of new drugs and vaccines.
• The IP system of the least developed 
countries and the countries with emerging 
economies is fostered by Switzerland.
10. Health determinants
Sustainably improve the economic, social 
and environmental determinants of health.
• Other sectors’ awareness of determinants 
is raised on the national and international 
level.
• Approaches and solutions for influencing 
health determinants are made suitable for 
application in practice.
• Implementation of health promotion strate-
gies is supported.
• Multi- and intersectoral cooperation and 
processes in operational programmes are 
used and supported.
11. E-health
Fully exploit the potential of technological 
developments and social media in the area 
of global health.
• Information and communication technolo-
gies adapted to the relevant context are 
deployed for health service users and 
providers.
• A web-based platform is established for 
communication with external partners.
InTERACTIOnS WITH OTHER POlICy AREAS
16  Cf. in particular “Declaration on the TRIPS agreement and public health”, 2001 (http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_trips_e.htm)
Objectives
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12. Communicable  
 disease surveillance
Further strengthen the international system 
for communicable disease surveillance and 
control.
• The International Health Regulations (IHR) 
are universally applied.
• National, regional and global preparedness 
for an influenza pandemic is improved.
• The WHO target of eliminating measles in 
Europe by 2015 is met.
• There is a reduction in the disease burden 
and mortality associated with the main 
poverty-related diseases (HIV/Aids, malaria 
and tuberculosis) and with waterborne 
diseases.
13. Health protection
Protect the public from health risks in the 
areas of food safety, radiological protection 
and chemicals.
• Protection in Switzerland is maintained at a 
high level through international cooperation, 
in particular with the EU.
• Measures are designed in a business-friend-
ly way, and non-tariff barriers to trade are 
avoided as far as possible.
• The Swiss vice-presidency (2011–2014) 
helps to strengthen the Codex alimenta-
rius as a programme for global food safety 
standards.
14. Health personnel 
Combat the global shortage and unequal 
distribution of health personnel.
• The WHO Global Code of Practice on the In-
ternational Recruitment of Health Personnel 
is implemented.
• From May 2012, Switzerland prepares a 
report every three years on the implementa-
tion of the WHO Code of Practice.
• The Swiss market takes into account the 
guidelines of the WHO Code of Practice in 
the training and recruitment of health per-
sonnel.
• Equal consideration is given to labour 
market needs in industrialised countries, 
countries with emerging economies and the  
least developed countries.
• The recruitment of health personnel in the 
least developed countries is accompanied 
by measures which strengthen their health 
systems. 
• Education and training for health workers is 
strengthened in Switzerland and worldwide.
15. Access to / quality of  
  therapeutic products
Improve access to essential (established 
and newly developed), good-quality, afford-
able medicines and medical devices.
• Support is provided for the provision and 
management of basic health services with 
essential medicines.
• Support is provided for the research and de-
velopment of new, affordable medicines and 
diagnostics through public-private partner-
ships.
• There are global efforts to combat the 
spread of falsified medicines.
16. non-communicable  
  diseases
Promote the prevention, diagnosis and 
treatment of non-communicable diseases.
• Switzerland advocates a coordinated in-
ternational approach to the prevention of 
non-communicable diseases and to health 
promotion.
• Under WHO leadership, Switzerland sup-
ports effective measures (e.g. a web-
based, international platform documenting 
international data availability) to implement 
objectives and voluntary commitments of 
government and private-sector actors to 
combat non-communicable diseases.
• Mental health is integrated into efforts to 
strengthen health systems.
• Switzerland consistently implements ex-
isting national prevention programmes and – 
as soon as it comes into force – the Federal 
Act on Prevention and Health Promotion 
(Prevention Act).
• Switzerland ratifies the WHO Framework 
Convention on Tobacco Control.
17. Drug policy
Establish internationally the fourfold policy 
(prevention, therapy and rehabilitation, 
harm reduction, and law enforcement and 
control).
• Switzerland retains the freedom which it has 
secured for itself in the international environ-
ment.
• In international drug policy, Switzerland’s 
fourfold approach17 (prevention, therapy 
and rehabilitation, harm reduction, and law 
enforcement and control) is more widely 
recognised. 
HEAlTH ISSUES
17  As specified in Art. 1a of the Narcotics Act (SR 812.121)
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• There is increased cooperation and sharing 
of information on illegal drugs, especially 
with European countries and the EU authori-
ties.
18. Humanitarian aid
Make available Switzerland’s capacities and 
skills for saving lives and restoring health in 
humanitarian crises.
• Switzerland provides emergency medical 
assistance in humanitarian crises.
• Switzerland participates in reconstruction 
efforts after disasters and crises, and con-
tributes to the stabilisation and long-term 
strengthening of public health in fragile 
states.
• Through prevention and advocacy, Swit-
zerland reduces risks and mitigates the 
impacts of crises and disasters.
19. Human rights
Promote and secure the right of everyone 
to the enjoyment of the highest attainable 
standard of physical and mental health.
• Based on the human rights principles of 
universality, indivisibility, interdependence, 
equality and non discrimination, participa-
tion and inclusion, accountability and rule 
of law, Art. 12 Para. 1 of the International 
Covenant on Economic, Social and Cultural 
Rights is implemented globally.
20. Maternal and child  
  health / sexual and  
  reproductive health
Promote maternal and child health, and 
sexual and reproductive health.
• Medical and social care is improved for ex-
pectant mothers in countries with high rates 
of infant and maternal mortality.
• The chances of survival of infants and moth-
ers are increased by improving access to 
health services for vulnerable groups.
• Switzerland helps to improve access to 
sexual and reproductive health information 
and services for women and men.
Objectives
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Switzerland is an active negotiating partner in WHO. Its positions are developed together
with the federal agencies involved in Swiss Health Foreign Policy.
33
The measures to improve coordination 
and coherence which were proposed in 
the Agreement on Health Foreign Policy 
Objectives in 2006 have been imple-
mented and are reaffirmed as permanent 
instruments in the new Swiss Health 
Foreign Policy. These established instru-
ments should ensure that interdepartmen-
tal cooperation remains as straightforward 
as possible. In addition, decisions are 
naturally also to be assured by standard 
mechanisms such as defined responsibili-
ties (see Annex I), departmental consulta-
tion and co-reporting procedures, and 
Federal Council decisions. With Instru-
ment 6, a new element has been intro-
duced to strengthen cooperation with 
non-governmental actors. Swiss Health 
Foreign Policy activities are to be coordi-
nated with Switzerland’s general foreign 
policy and actively communicated, build-
ing on Switzerland’s particular strengths. 
Instrument 1: Coordination office for 
Health Foreign Policy
The Sectoral Foreign Policies Division 
(SFPD) is the FDFA’s coordination office 
for Swiss Health Foreign Policy (currently 
the Transport, Energy and Health sec-
tion). This office is responsible for collect-
ing and forwarding relevant information 
from the FDFA to the other authorities 
concerned within the Federal Administra-
tion. In principle, communication with the 
Swiss diplomatic missions should pass 
through the coordination office, although 
other arrangements may be made with 
the FDFA in justified cases. The coordi-
nation office serves as the contact point 
for enquiries from the FOPH and other 
authorities within the Federal Administra-
tion. It is also responsible for coordina-
tion of health matters within the FDFA. 
The coordination office also seeks to 
ensure the coherence of Swiss Health 
Foreign Policy as part of Switzerland’s 
overall foreign policy, by weighing up the 
various foreign policy interests and, at the 
interdepartmental level, optimising the 
safeguarding of interests and the alloca-
tion of resources.
Instrument 2: Information platform  
for Health Foreign Policy
CH@WORLD is a wholly web-based in-
formation hub and consultation platform, 
supporting and facilitating cooperation in 
the area of Swiss foreign policy. On it, the 
FDFA has established a sectoral area for 
health, with links to the relevant bilateral 
or multilateral dossiers. Accessible to 
all interested parties within the Federal 
Administration, CH@WORLD provides a 
shared interface which allows users to 
conduct consultations, publish com-
ments, look up information and upload 
documents. CH@WORLD thus ensures 
that all parties involved in Swiss Health 
Foreign Policy within the Federal Ad-
ministration have the same background 
information and planning documents at 
their disposal. CH@WORLD is generally 
used as a key communication tool by all 
parties concerned. 
Swiss Health Foreign Policy activities 
are to be coordinated with Switzer-
land’s general foreign policy
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Instrument 3: Development of policy 
papers on Health Foreign Policy is-
sues and strengthening of academic 
expertise
The FOPH, SDC, and the Sectoral 
Foreign Policies Division of the FDFA, in 
consultation with the other parties con-
cerned within the Federal Administration, 
prepare papers on specific aspects of 
Swiss Health Foreign Policy. These pa-
pers support discussion and subsequent 
clarification of Switzerland’s position on 
important Health Foreign Policy issues. 
To date, papers have been produced on 
the migration of health personnel and the 
implementation of the WHO Global Strat-
egy and Plan of Action on Public Health, 
Innovation and Intellectual Property; 
papers will be produced on international 
food safety and on bilateral cooperation 
in the health field. At the same time, the 
FDHA and FDFA are strengthening inter-
national Geneva through the consolida-
tion of academic expertise in international 
health. 
Instrument 4: Interdepartmental  
structures
The Interdepartmental Conference on 
Health Foreign Policy (IK GAP18), which 
is held annually, is jointly headed by the 
FOPH Director, the SDC Director and 
the FDFA State Secretary. The IK GAP 
includes representatives of the FDFA, 
FDHA, FDJP, DDPS, FDEA and DETEC, 
as well as the Conference of Cantonal 
Directors of Public Health. Other federal 
authorities are invited according to the 
particular requirements and/or interests.
The IK GAP defines current priorities and 
joint projects. In addition, the IK GAP de-
cides on joint annual planning, including 
disclosure of the resources available for 
this purpose. As a contribution to moni-
toring and transparency, the status of 
implementation of measures is reported 
annually to the IK GAP. 
The IK GAP is supported by the interde-
partmental working groups on health for-
eign policy (IdAG GAP19) and on health, 
innovation and intellectual property (IdAG 
GIGE20). Depending on the specific the-
matic emphasis, the IdAG GAP is jointly 
led by the heads of two of the follow-
ing divisions: Sectoral Foreign Policies 
Division of FDFA, International Affairs of 
FOPH, and Eastern and Southern Africa 
of the SDC. The IdAG GIGE is jointly led 
by the Divisional Heads of FOPH Interna-
tional Affairs and IPI International Affairs. 
Both of the interdepartmental working 
groups hold regular meetings at least 
twice a year; as far as is possible and 
appropriate, these are scheduled back to 
back. In turn, both the IdAG GAP and the 
IdAG GIGE can convene ad hoc working 
groups on specific issues. The experi-
ence and concerns of non-governmental 
health actors are consulted according to 
the particular topic and available exper-
tise. 
An executive-level support group – 
comprising representatives of the SFPD, 
SDC, FOPH, SER, IPI, SECO and OPET21 
– meets at least twice a year to promote 
policy coherence and, in the event of 
differences of opinion concerning current 
Instruments
18  From German: Interdepartementale Konferenz Gesundheitsaussenpolitik
19 From German: Interdepartementale Arbeitsgruppe Gesundheitsaussenpolitik
20 From German: Interdepartementale Arbeitsgruppe Gesundheit, Innovation und Geistiges Eigentum
21 Other federal authorities are invited according to the particular requirements and/or interests.
Priorities are set and joint projects 
determined every year
35
dossiers, to reach a consensus or refer 
such questions to the standard decision-
making mechanisms at the Office Direc-
tor, Department or Federal Council level. 
The support group provides the two inter-
departmental working groups with brief 
feedback on any agreements reached.
Apart from this interdepartmental work -
ing structure specifically concerned  
with Swiss Health Foreign Policy, there 
are various additional interdepartmental  
bodies which may deal with policy is -
sues. Here, mention should be made of  
the interdepartmental working group on  
European Integration (IDA EU), the inter -
 departmental group on sustainable de-
velopment (ISDC), the Interdepartmental 
Committee for International Development  
and Cooperation (ICDC), as well as the 
interdepartmental working group for 
migration (IAM-Plenum) and its sub-
committee for international migration 
cooperation (IMZ-Ausschuss).
Instrument 5: Staff exchange,  
foreign missions and secondments
If possible, a senior position within the 
FOPH International Affairs Division will 
continue to be held by a member of the 
diplomatic staff of FDFA. The health 
dossier is to be explicitly assigned to 
a member of staff at each of the mis-
sions in Geneva, Brussels and New York. 
Health topics are to be included in the 
annual objectives of these three missions 
and also, where appropriate, in the ob -
jectives of other Swiss diplomatic mis-
sions. In addition, the SDC will increas-
ingly establish secondments with partner 
institutions.
Instrument 6: Regular exchanges  
with stakeholders
This instrument is designed to ensure 
closer involvement of non-governmental 
actors in Swiss Health Foreign Policy. To 
this end, a general meeting on the policy 
with all relevant actors is to be held each  
year. At these events, the external part-
ners will also be consulted on the annual 
priorities to be adopted by the IK GAP. 
Also planned are consultations on certain 
issues. These may be written consult-
ations, invitations to preparatory meet-
ings, working groups on specific topics, 
or participation in delegations to inter-
national negotiations. To support such  
consultations, it is to be assessed  
whether the establishment of a web-
based communication platform is 
appropriate and feasible at reasonable 
expense.
Stakeholders are being increas-
ingly included in Swiss Health 
Foreign Policy
36
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Wall painting from Tanzania. Tanzania is an important partner for Switzerland both in education  
and in research and development cooperation.
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the measures needed to master future 
challenges without additional financial 
expenditure by the federal government.
The joint Swiss Health Foreign Policy is 
to be principally implemented with the 
resources committed by the FDFA, the 
FDHA and the other federal authorities 
concerned.
The growing importance of Swiss Health 
Foreign Policy at the bilateral and mul-
tilateral level makes it necessary to use 
the resources available for its tasks as 
efficiently as possible. Resources are to 
be released by a steady improvement 
in the cost-benefit of measures and by 
allocating means according to the priori-
ties set. The objective of this is to finance 
The costs of the measures should 
be financed as much as possible 
without additional financial expend-
itures by the federal government
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Annex I
Federal bodies involved in Swiss Health Foreign Policy
ANNEXES 10
UNIT OF FEDERAL 
ADMINISTRATION
RESPONSIBILITIES
DPA22 The Directorate of Political Affairs of the FDFA safeguards Switzerland’s foreign policy 
interests and provides optimum bilateral and multilateral relations. It promotes Switzerland’s 
political integration in Europe, and assures the coherence of Swiss positions towards inter-
national organisations and bodies and the foreign policy coordination in migration, economy, 
financial center, environment, health and science policies.
SDC23 The Swiss Agency for Development and Cooperation is the agency within the FDFA respon-
sible for overall coordination, with other federal authorities, of international development 
cooperation and cooperation with Eastern Europe; it is also responsible for Switzerland’s 
humanitarian aid.
IO24 The Integration Office is the federal centre of expertise for European integration policy 
matters. Its responsibilities include the preparation of treaties with the European Union. It 
negotiates such treaties in collaboration with the competent authorities and coordinates their 
implementation and further development. The activities of the IO are supported by the Mis-
sion of Switzerland to the EU.
FOPH25 The Federal Office of Public Health is the authority responsible for human health, for national 
health policy, for Switzerland’s contribution to international health policy, for medical and  
accident insurance, and for certain aspects of consumer protection.
FSO26 The Federal Statistical Office is the authority responsible for Switzerland’s official statistics.
SER27 The State Secretariat for Education and Research is the federal authority responsible for 
national and international matters relating to general and university education, research and 
space.
Swissmedic28 Swissmedic is Switzerland’s central agency for authorisation and supervision of therapeutic 
products.
FOM29 The Federal Office for Migration is the authority responsible for matters relating to immi-
gration and emigration, legislation on foreign nationals, asylum and refugees, as well as 
naturalisation.
IPI30 The Swiss Federal Institute of Intellectual Property is the authority responsible for matters  
of intellectual property law.
FOSPO31 The FOSPO, within the defined political framework, promotes the diverse and sustainable 
development of sport for young people, adults and senior citizens.
22 Ordinance on the Organisation of the FDFA (SR 172.211.1, Art. 7)
23 See also: Ordinance on the Organisation of the FDFA (SR 172.211.1, Art. 9)
24 Ordinance on the Organisation of the FDFA (SR 172.211.1, Art. 13) / Ordinance on the Organisation of the FDEA (SR 172.216.1, Art. 13)
25 Ordinance on the Organisation of the FDHA (SR 172.212.1, Art. 9)
26 Ordinance on the Organisation of the FDHA (SR 172.212.1, Art. 10)
27 Ordinance on the Organisation of the FDHA (SR 172.212.1, Art. 13)
28 See also: Ordinance on the Organisation of the Swiss Agency for Therapeutic Products (SR 812.216)
29 Ordinance on the Organisation of the FDJP (SR 172.213.1, Art. 12)
30 Ordinance on the Organisation of the FDJP (SR 172.213.1, Art. 29)
31 Ordinance on the Organisation of the DDPS (SR 172.214.1, Art. 15)
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UNIT OF FEDERAL 
ADMINISTRATION
RESPONSIBILITIES
AFLO32 The Armed Forces Logistics Organisation supports the Swiss Army in all situations and in all 
processes at home and abroad. The AFLO’s tasks include: replenishment, evacuation and 
maintenance of material and systems, medical services for the Forces, transport of people 
and goods, provision and operation of infrastructures and systems as well as cross section 
services for the department’s defence sector.
SECO33 The State Secretariat for Economic Affairs is the federal centre of expertise responsible for 
all core issues of economic policy, including employment and foreign economic policy, and 
also, together with the SDC, for development policy and cooperation with Eastern Europe.
OPET34 The Federal Office for Professional Education and Technology is the centre of expertise re-
sponsible for national and international matters relating to vocational education and training, 
universities of applied sciences, and technology and innovation policy; it is also responsible 
for the coordination of mutual recognition of qualifications with the EU and EFTA and, within 
its area of competence, for the recognition of foreign qualifications.
FOAG35 The Federal Office for Agriculture is the centre of expertise responsible for agricultural mat-
ters.
FVO36 The Federal Veterinary Office is the centre of expertise responsible for animal health, animal 
welfare and the protection of endangered species in international trade.
FOEN37 The Federal Office for the Environment is the authority reponsible for environmental matters.
32 See also: Ordinance on the Organisation of the DDPS (SR 172.214.1, Art. 10)
33 Ordinance on the Organisation of the FDEA (SR 172.216.1, Art. 5)
34 Ordinance on the Organisation of the FDEA (SR 172.216.1, Art. 6)
35 Ordinance on the Organisation of the FDEA (SR 172.216.1, Art. 7)
36 Ordinance on the Organisation of the FDEA (SR 172.216.1, Art. 8)
37 Ordinance on the Organisation of the DETEC (SR 172.217.1, Art. 12)
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Annex II
list of abbreviations
AFLO   Armed Forces Logistics Organisation
DDPS   Federal Department of Defence, Civil Protection and Sport
DETEC   Federal Department of the Environment, Transport, Energy and Communications
DNDi   Drugs for Neglected Diseases initiative
DPA   Directorate of Political Affairs
DPIL   Directorate of Public International Law
ECDC   European Centre for Disease Prevention and Control
EFSA   European Food Safety Authority
EFTA   European Free Trade Association
EU   European Union
EWRS   Early Warning and Response System
FDEA   Federal Department of Economic Affairs
FDFA   Federal Department of Foreign Affairs
FDHA   Federal Department of Home Affairs
FDJP   Federal Department of Justice and Police
FIND   Foundation for Innovative New Diagnostics
FMH   Swiss Medical Association
FOAG   Federal Office for Agriculture
FOCP   Federal Office for Civil Protection
FOEN   Federal Office for the Environment
FOM   Federal Office for Migration
FOPH   Federal Office of Public Health
FOSPO   Federal Office of Sport
FSIO   Federal Social Insurance Office
FSO   Federal Statistical Office
FVO   Federal Veterinary Office
GAVI   Global Alliance for Vaccines and Immunisation
GDK   Swiss Conference of the Cantonal Ministers of Public Health
GELIKO   Swiss National Conference of Health Leagues
GFATM   Global Fund to Fight Aids, Tuberculosis and Malaria
H+    Swiss Hospital Association 
HSD   Human Security Division of the FDFA 
HUG   Geneva University Hospitals
ICDC   Interdepartmental Committee for International Development and Cooperation
IAM   Interdepartmental working group on migration
IdA EU   Interdepartmental group on the EU
IdAG GAP  Interdepartmental working group on Health Foreign Policy
IdAG GIGE  Interdepartmental working group on health, innovation and intellectual property
IDANE   Interdepartmental committee on sustainable development
IHEID   Graduate Institute of International and Development Studies
IK GAP   Interdepartmental Conference on Health Foreign Policy
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ILO   International Labour Organization
IMZ   Subcommittee for International Migration Cooperation
IO   FDFA/FDEA Integration Office
IOD   United Nations and International Organisations Division of the FDFA 
IP   Intellectual Property
IPI   Swiss Federal Institute of Intellectual Property
MMI   Medicus Mundi International
MMS   Medicus Mundi Switzerland
MMV   Medicines for Malaria Venture
MSF   Médecins Sans Frontières
NEOC   National Emergency Operations Centre
NGO   Non-governmental organisation
Obsan   Swiss Health Observatory
OECD   Organisation for Economic Co-operation and Development
OPET   Federal Office for Professional Education and Technology
SFPD   Sectoral Foreign Policies Division of the FDFA 
PDP   Product development partnership
pharmaSuisse  Swiss Association of Pharmacists
PPP   Public-private partnership
RASFF   Rapid Alert System for Food and Feed
SAICM    Strategic Approach to International Chemicals Management
SBK/ASI   Swiss Professional Association for Nurses
SDC   Swiss Agency for Development and Cooperation
SECO   State Secretariat for Economic Affairs
SER   State Secretariat for Education and Research
SGGP/SSPS  Swiss Society for Health Policy
SNSF   Swiss National Science Foundation
SRC   Swiss Red Cross
Swiss TPH  Swiss Tropical and Public Health Institute
TRIPS   Trade-Related Aspects of Intellectual Property Rights
UN   United Nations
UNIOD   United Nations and International Organisations Division of the FDFA
UNAIDS   Joint United Nations Programme on HIV/Aids
UNFPA   United Nations Population Fund
UNICEF   United Nations Children’s Fund
WHO   World Health Organization
WTO   World Trade Organization
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Annex III
Overview of the twenty objectives
Global health  
architecture
Health diplomacyStrengthening of 
health systems
Health personnel
Access to / quality of 
therapeutic products
Economic interests
Health protection
Infectious disease 
control
Intellectual property 
protection
Drug policy
Humanitarian aid
Human rights
Non-communicable 
diseases
Health determinants
International Geneva
E-health
Role of WHO
Maternal and  
child health /  
sexual and repro-
ductive health
Research
Relations with EU
Governance
Interactions with 
other policy areas
Health issues
Health interests of  
Swiss population
Global responsibility of  
Switzerland for health
General  
interests
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